Surgery Partners (NASDAQ:SGRY) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a $43.00 target price on the stock.

Other research analysts have also issued research reports about the company. Barclays began coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an equal weight rating and a $35.00 price objective for the company. Benchmark reiterated a buy rating and set a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, May 1st. Citigroup cut their target price on Surgery Partners from $42.00 to $38.00 and set a buy rating on the stock in a research note on Wednesday, May 8th. StockNews.com upgraded Surgery Partners from a sell rating to a hold rating in a research note on Thursday, March 21st. Finally, Macquarie assumed coverage on Surgery Partners in a research note on Friday, June 28th. They set an outperform rating and a $31.00 target price on the stock. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and an average price target of $41.38.

Surgery Partners Stock Up 1.3 %

Shares of NASDAQ:SGRY opened at $23.72 on Tuesday. Surgery Partners has a 52-week low of $22.05 and a 52-week high of $44.93. The firm has a market capitalization of $3.01 billion, a P/E ratio of 27.66, a P/E/G ratio of 1.80 and a beta of 2.78. The stock has a 50 day moving average price of $25.40 and a 200-day moving average price of $28.70. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The company had revenue of $717.40 million during the quarter, compared to analyst estimates of $707.66 million. As a group, equities research analysts anticipate that Surgery Partners will post 0.88 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In other news, insider Danielle Burkhalter sold 6,000 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total value of $158,340.00. Following the transaction, the insider now directly owns 30,354 shares in the company, valued at approximately $801,042.06. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 2.30% of the company’s stock.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP raised its holdings in Surgery Partners by 3.7% in the 4th quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock worth $266,098,000 after purchasing an additional 295,476 shares during the period. Vanguard Group Inc. raised its holdings in Surgery Partners by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after purchasing an additional 61,400 shares during the period. Clearbridge Investments LLC raised its holdings in Surgery Partners by 4.7% in the 4th quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock worth $176,766,000 after purchasing an additional 247,762 shares during the period. Janus Henderson Group PLC raised its holdings in Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after purchasing an additional 2,473,282 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Surgery Partners by 8.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,840,212 shares of the company’s stock valued at $58,870,000 after acquiring an additional 149,146 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.